Antibacterial non-glycosidase activity of invertebrate destabilase-lysozyme and of its helical amphipathic peptides
Basic science published in Chemotherapy (2006)
Abstract
BACKGROUND: Since bactericidal properties of some lysozymes are independent of their glycosidase activity, we have investigated this phenomenon for destabilase-lysozyme (DL) from medicinal leech (Hirudo medicinalis). METHODS: Glycosidase activity was determined on Micrococcus luteus, non-enzymatic antibacterial activity of heat-treated DL and of synthetic peptides alpha1, alpha2 and alpha3 (fragments of its primary structure) on M. luteus, Escherichia coli, Bacillus brevis and Streptomyces chrysomallus. RESULTS: Glycosidase activity disappeared after the heating of native DL at 100 degrees C for 40 min. Antibacterial activity of heat-treated DL for M. luteus MDMSU128 and MDMSU140 expressed as minimal inhibitory concentration was 9.8.10(-8) and 12.10(-8) M, respectively, and to E. coli MDMSU52 11.10(-8) M. Antibacterial activity of synthetic peptide alpha1 for M. luteus MDMSU128 and for E. coli MDMSU52 was 8.3.10(-5) and 4.9.10(-5) M, respectively. CONCLUSION: DL is the first invertebrate lysozyme with combined enzymatic and non-enzymatic antibacterial action.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Zusammenfassung
Heat-treated destabilase retains antibacterial activity (MIC 9.8-12x10^-8 M) against M. luteus and E. coli even with glycosidase function abolished.
Warum dies für die Hirudotherapie relevant ist
This study investigated the antibacterial properties of destabilase-lysozyme (DL) from the medicinal leech (Hirudo medicinalis), specifically examining its non-enzymatic, non-glycosidase antibacterial action. It is highly relevant to the leech secretome, demonstrating that heat-treated DL and synthetic peptides derived from its structure retain potent antibacterial activity against pathogens like Micrococcus luteus and Escherichia coli. This reveals that leech-derived molecules possess a dual enzymatic and non-enzymatic defense mechanism. However, the scope is limited to in vitro microbial sensitivity testing of isolated or synthetic leech peptides, providing no data on the efficacy of these compounds in live animal models or clinical hirudotherapy.
Zitation
Antibacterial non-glycosidase activity of invertebrate destabilase-lysozyme and of its helical amphipathic peptides.
Zavalova LL et al. · Chemotherapy, 2006
Verwandter klinischer Kontext
Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist
Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026